2020 Plenary Keynote: Tackling Undruggable Oncoproteins: Lessons from the VHL Tumor Suppressor Protein
William G. Kaelin, Jr., MD
Professor and Investigator, Howard Hughes Medical Institute, Oncology, Dana-Farber Cancer Institute
A Nobel laureate, Dr. Kaelin received the 2019 Nobel Prize in Physiology or Medicine. Dr. Kaelin is a member of the American Society of Clinical Investigation, the American College of Physicians, the National Academy of Sciences and the
National Academy of Medicine.
PANEL DISCUSSION: De-Risking Early Drug Discovery
Moderator: Nadeem Sarwar, PhD
Founder & President, Eisai Center for Genetics Guided Dementia Discovery, Eisai, Inc.
Anthony A. Philippakis, PhD
Chief Data Officer, Data Sciences & Data Engineering, Broad Institute, Venture Partner, GV
Andrew Plump, MD, PhD
President, Research & Development, Takeda Pharmaceuticals, Inc.
Research Continues: Join the Discovery on Target Virtual Community
As the coronavirus situation further develops, the health and well-being of our community remains our top priority. We would never have dreamt our world would be facing such uncertain times. Our team has been working for months behind
the scenes planning the 2020 event, monitoring and adapting to these new circumstances. We’re excited we can still support your scientific collaborations – now virtually – this fall.
Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. DOT highlights advances in current and emerging “hot” targets and
technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
We aim to meet your research needs. Delegates can virtually visit numerous concurrent sessions and – with on-demand access to presentations – benefit even from those you can’t attend live. You can customize
your experience further through focused short courses, interactive breakout discussions, and virtual networking options that help you engage with experts and solutions providers from the comfort of home.
Daniel Nomura, PhD
University of California Berkeley
David Langenau, PhD
Massachusetts General Hospital; Harvard Medical School
Gabriela Chiosis, PhD
Sloan Kettering Institute for Cancer Center, Cornell and The Rockefeller University
Guido Zaman, PhD
Jennifer C. Petter, PhD
Jian Jin, PhD
Icahn School of Medicine at Mount Sinai
Marla Weetall, PhD
Priscilla Yang, PhD
Harvard Medical School
Stewart Fisher, PhD
C4 Therapeutics, Inc.
Terrence P. Kenakin, PhD
University of North Carolina at Chapel Hill
Anna Greka, MD, PhD
BWH/Harvard Medical School/Broad Institute
Lakshmi Krishnan, PhD
National Research Council, Canada
Linda Griffith, PhD
Massachusetts Institute of Technology
Dirk Kessler, PhD
Rebecca A. Taub, MD